PolarityTE — Investor Presentation (January 2018)
29 slides from PolarityTE's investor presentation, Jan 9, 2018
Slide 1: PolarityTE: where self regenerates self
Slide 2: Forward Looking Statements
Pag FORWARD LOOKING STATEMENTS Ls This presentation contains forward-looking statements and projections. The company makes no express or implied representation or warrant as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy and complete
Slide 3: The Problem with Regenerative Medicine is Tissue Engineering
The Problem with Regenerative Medicine—is Tissue Engineering
Slide 4: The Problem with Tissue Engineering
The Problem with Tis The Tissue Engineering Triad Overly Reductionist Approaches to Myopic Theories SIGNALING | (@3, POGF. BHP) Keratinocytes ‘Skin Biopsy —» Ceil Isolation Y ME APPROPRIATE y REGENERATION ‘OF Tissue/ “ORGANS eg, omeobiasts Rorotiaets) Bere Allogenic | Triads, Single Cell Suspension
Slide 5: The Solution to Regenerative Medicine is Polarity
The Solution to Regenerative Medicine—is Polarity Polarized Interfaces Drive Embryogenesis, Histogenesis and Tissue Regeneration -larsi-ty: the tendency of living organisms or parts to REDEE is Ue LCEE on en | i and lowermost) ends, or to grow of orient ina particular direction. Polarity = Dynamic I
Slide 6: PolarityTE - Welcome to the SHIFT
PolarityTE™ - Welcome to the SHIFT™ a EVOLVING TECHNOLOGY PLATFORMS AND PRODUCTS Weare a clinical stage, commercial biotechnology and regenerative materials company a 4 with new and expanding technology platforms which are utilized to create functionally- \ polarized tissues for use in clinical medi
Slide 7: SkinTE - Now Commercially Available and in Use Nationwide
SkinTE™- Now Commercially Available and in Use Nationwide SkinTE™ is intended to be used by physicians or other appropriate healthcare providers for homologous uses of the skin and integumentary system. Patients who have suffered from an event, disease, process or who have an acquired defect that ha
Slide 8: PolarityTE Tackles the Regenerative Wound Care Market
PolarityTE™- Tackles the Regenerative Wound Care Market Current markets remain untapped with myopically-redundant and synthetic forms of tissue engineering products which do not utilize the functional and inherently regenerative tissues of the patient Global markets for tissue engineering and regene
Slide 9: SkinTE - A Simple Process for an Exceptional Product
| SkinTE™- A Simple Process for an Exceptional Product A Product for All Medical Providers Surgeons, Medical Doctors, Physician Assistants, Nurses, Wound Care Providers, Medics Patient Wounds Acute wounds, chronic wounds, acute burns, burn reconstruction, scar revision, surgical reconstruction, repl
Slide 10: ai)
ai)
Slide 11: PolarityTE Real-Time Assistant App
PolarityTE™ Real-Time Assistant App PolarityTE RTA
Slide 12: A Proven Concept and an Evolving Tangible Technology
| A Proven Concept and an Evolving Tangible Technolog EXPERIMENTAL EXPERIMENTAL ‘Transplantation of the LGR6’ Epithelial Stem “ell into Full-Thickness Cutaneous Wounds Results in Enhanced Healing, Nascent Hair Follicle Development, and Augmentation Stimulation of the Follicular Bulge LGR5' and LGR6'
Slide 13: The Conventional Therapies and Fundamental Limitations
The Conventional Therapies and Fundamental Limitations |
Slide 14: Conventional Therapies and Fundamental Limitations
pies and mental Limitati + Acellular scaffolds or matrices lack the innate ability to regenerate tissue and rely on surrounding tissue in-growth and ultimately secondary skin grafts for definitive coverage Allogeneic/Xenogeneic Cells: ic (tissue or cells derived from another person) or Xenograft (an
Slide 15: Conventional Therapies and their Fundamental Limitations
pies and their Fundamental Limitations A Massive Market Saturated with Stagnant Products Lacking \[E Fundamental Principles and Building Blocks for True Functional Skin Regeneration Regenerative Cellular Regenerates Full -Thickness Company Cellular Tissue Source Stem Cell Architecture Functional Ski
Slide 16: The SkinTE Difference: Skin Regenerates Skin
The SkinTE™ Difference Simply Put—Skin Regenerates Skin Embracing Complex Simplicity While other conventional regenerative medicine, cell therapy and tissue engineering companies and products try to reconstruct skin substitutes from a variety of cells, molecules, genes and scaffolds in order to circ
Slide 17: Full-Thickness Skin Regeneration in Full-Thickness Wounds
Full-Thickness Skin Regeneration in Full-Thickness Wounds Control W orld's First: PolarityTE™ Develops Full thickness Hair-Bearing Skin for Treatment of Burns, Wounds and Scars ploy {sults in Progres 6 Full-thickness Functionally-Polarized Skin ‘SkinTE™ Expands, into Residual Sear Regions e » 4 Comp
Slide 18: Comparing the Clinical Standard of Care to SkinTE
Comparing the Clinical Standard of Care to SkinTE™ Native Scar Healed Wound _Native Skin Full-Thickness Allograft Autograft \\\ Margin Native skin t Skin defects heal through a process of wound contraction and often scar formation. While skin grafts reduce contraction, patients still have scars. Ski
Slide 19: SkinTE - Mid-Stage Intelligent and Dynamic Healing
SkinTE™- Mid-Stage Intelligent and Dynamic Healing tage Native Contracting Wound SkinTE™ Mid-Stage Regenerative Wou a Contraction and Migration pitta gration Coturane Convergence with Native Sn i; Native Healed and Contracted Wound ¢ < Pseudo epithelium Covering the Underlying Sear SkinTE™ Regenerat
Slide 20: Our Technology Platforms
Pp Our Technology Platforms TheCore “TE” Products “TE” technology was discovered through careful observation and the study of neogenesis within systems, regenerative tissue healing and cellular propagation mechanisms in real-time. With this, the PolarityTE™ core “TE” platform technology has develope
Slide 21: The Core TE Advantage - Complex Simplicity Made Reality
The Core “TE” Advantage- Complex Simplicity Made Reality Autologous—From the Patient for the Patient: The immune system is highly complex and has evolved to recognize anything that is not truly self.” Our foundational platform is built on using autologous tissue(s), avoiding allogeneic tissue reject
Slide 22: The Core TE Product Line - Simply Intuitive Product
The Core “TE” Pro ine - Simply Intuitive Product Preclinical Development Clinical Deployment Tissue Product Ex Vivo Optimization Prototype Modeling Studies Market Entry & Commercialization 2H2017 2H 2017 L 2H 2018 2H 2018 BD polarityte Development Pipeline of PdlarityTE Core “TE” Products. A pipelin
Slide 23: OsteoTE: Regeneration of Full-Thickness Bone Defects
OsteoTE™: Regeneration of Full-Thickness Bone Defects é¥ OS PEE Oste6lE Welcome to the Shift™ Craniofacial=Spine—Long Bone Joints Hand Dental a “a de
Slide 24: SkinTE Commercial Launch Triggered
‘SkinTE™ Commercial Launch Triggered PolarityTE™ Growth- Public, Commercial, Scaling and Evolving 2 Clinical application initiated across all wound types: ® Chronic wounds, reconstructive wounds, acute burns, surgical wounds Scar revision: Removal of healed standard of care skin grafts and replaceme
Slide 25: The PolarityTEAM - Executive Management
The PolarityTEAM - Executive Management Di Ne + Denver Lough, MD, PhD Edward Same = a tree aes, ‘Cameron Hoyler J.D. Chief Erect Office & Chairman Executive Vice President Executive Vice Presifent ie Legal Officer General Course Inventor/innovator behind patented BAS trom University of Pennsytvania:
Slide 26: The PolarityTEAM - Board of Directors
The PolarityTEAM - Board of Directors =>. ae... Chairman & Chief Executive Officer Edward (Ned) Swanson, MD Executive Vice President, COO, Director John Stetson Executive Vice President, CFO, Director Corporation, Medicis Pharmaceutical Corporation (acquired by Valeant for $2.6B), EntreMed, Inc., MR
Slide 27: Medical Advisory Board
cal Advisory Board
Slide 28: We are PolarityTE - And Welcome to the SHIFT
We are PolarityTE™-And Welcome to the SHIFT™ PolarityTE™, Inc. (NASDAQ: COOL) The New Paradigm of Regenerative Medicine is Here And This Time it is Real with a Proven Platform Technology A Regenerative Medicine Company Like No Other A revolutionary and proprietary platform technology developing prod
Slide 29: Contact PolarityTE
Contact PolarityTE™ Corporate Contact PolarityTE™ Support Contact PolarityTE™ Investor Relations Website: www.PolarityTE.com Customer Service: (800) 560-3983 John Stetson CFO Email: ParadigmShift@PolarityTE.com CustomerService@PolarityTE.com _ Investor Relations: (385) 560-3983 InvestorRelations@Pol